Skip to main content
Erschienen in: International Journal of Colorectal Disease 1/2005

01.01.2005 | Original Article

Impact of vasoactive intestinal polypeptide and gastrin-releasing peptide on small bowel microcirculation and mucosal injury after hepatic ischemia/reperfusion in rats

verfasst von: Ingo Leister, J. Sydow, T. Stojanovic, L. Füzesi, B. Sattler, M. Heuser, H. Becker, P. M. Markus

Erschienen in: International Journal of Colorectal Disease | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

Alterations in microvascular perfusion of the intestine after hepatic ischemia/reperfusion have been suggested as an important cause of postoperative septic complications. We therefore investigated small bowel microcirculation and mucosal injury after liver ischemia/reperfusion in a rat model. Furthermore, we analyzed the effects of the regulatory peptides vasoactive intestinal polypeptide and gastrin-releasing peptide for their splanchnic vasoactivity.

Methods

Hepatic ischemia was induced by clamping of the left hepatic artery and vein for 40 min, followed by 60 min of reperfusion. The control group was treated similarly, but without clamping of the liver vessels. Ten minutes after clamping of the hepatic vessels, vasoactive intestinal polypeptide or gastrin-releasing peptide, respectively, were continuously infused intravenously in the experimental groups. Small bowel microcirculation and mucosal injury were assessed using intravital microscopy and the Chiu-score, respectively.

Results

The functional capillary density of the small intestine following ischemia and reperfusion of the left hepatic lobe significantly decreased compared to normal controls in both the mucosa and the smooth intestinal muscle. Red blood cell velocity decreased, whereas leukocyte–endothelium adherence, stasis index and the mucosal injury score increased. Administration of vasoactive intestinal polypeptide resulted in an increase of functional capillary density in the mucosa and of the red blood cell velocity and a decrease in the stasis index. The mucosal injury score was significantly higher in reperfused animals without treatment. The application of gastrin-releasing peptide resulted in an isolated increase of the red blood cell velocity. Leukocyte adherences could not be altered by the regulatory peptides.

Conclusion

We conclude that hepatic ischemia/reperfusion injury leads to significant alterations of small bowel microcirculation and mucosal injury. Vasoactive intestinal polypeptide and gastrin-releasing peptide attenuate the damage in a different manner.
Literatur
1.
Zurück zum Zitat Horie Y, Wolf R, Miyasaka M, Anderson DC, Granger DN (1996) Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats. Gastroenterology 111:666–673PubMed Horie Y, Wolf R, Miyasaka M, Anderson DC, Granger DN (1996) Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats. Gastroenterology 111:666–673PubMed
2.
Zurück zum Zitat Post S, Menger MD, Rentsch M, Gonzalez AP, Herfarth C, Messmer K (1992) The impact of arterialization on hepatic microcirculation and leukocyte accumulation after liver transplantation in the rat. Transplantation 54:789–794PubMed Post S, Menger MD, Rentsch M, Gonzalez AP, Herfarth C, Messmer K (1992) The impact of arterialization on hepatic microcirculation and leukocyte accumulation after liver transplantation in the rat. Transplantation 54:789–794PubMed
3.
Zurück zum Zitat Henrion J (2000) Ischemia/reperfusion injury of the liver: pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis. Acta Gastroenterol Belg 63:336–347PubMed Henrion J (2000) Ischemia/reperfusion injury of the liver: pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis. Acta Gastroenterol Belg 63:336–347PubMed
4.
Zurück zum Zitat Leister I, Mbachu EM, Post S, Samel ST, Stojanovic T, Gutt CN, Becker H, Markus PM (2002) Vasoactive intestinal polypeptide and gastrin-releasing peptide attenuate hepatic microvasculatory disturbances following intestinal ischemia and reperfusion. Digestion 66:186–192CrossRefPubMed Leister I, Mbachu EM, Post S, Samel ST, Stojanovic T, Gutt CN, Becker H, Markus PM (2002) Vasoactive intestinal polypeptide and gastrin-releasing peptide attenuate hepatic microvasculatory disturbances following intestinal ischemia and reperfusion. Digestion 66:186–192CrossRefPubMed
5.
Zurück zum Zitat Serizawa A, Nakamura S, Suzuki, Baba S, Nakano M (1996) Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion. Hepatology 23:1656–1663CrossRefPubMed Serizawa A, Nakamura S, Suzuki, Baba S, Nakano M (1996) Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion. Hepatology 23:1656–1663CrossRefPubMed
6.
Zurück zum Zitat Suzuki S, Serizawa A, Sakaguchi T, Tsuchiya Y, Kojima Y, Okamoto K, Kurachi K, Konno H, Fujise Y, Baba S, Nakamura S (2000) The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. Transplantation 69:2267–2273CrossRefPubMed Suzuki S, Serizawa A, Sakaguchi T, Tsuchiya Y, Kojima Y, Okamoto K, Kurachi K, Konno H, Fujise Y, Baba S, Nakamura S (2000) The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. Transplantation 69:2267–2273CrossRefPubMed
7.
Zurück zum Zitat Ruh J, Schmidt E, Vogel F (2003) Effect of N-acetylcysteine on microcirculation of mucosa in rat ileum in a model of intestinal inflammation. Dig Dis Sci 48:882–889CrossRefPubMed Ruh J, Schmidt E, Vogel F (2003) Effect of N-acetylcysteine on microcirculation of mucosa in rat ileum in a model of intestinal inflammation. Dig Dis Sci 48:882–889CrossRefPubMed
8.
Zurück zum Zitat Neviere R, Chagnon JL, Teboul JL, Vallet B, Wattel F (2002) Small intestine intramucosal PCO(2) and microvascular blood flow during hypoxic and ischemic hypoxia. Crit Care Med 30:379–384 Neviere R, Chagnon JL, Teboul JL, Vallet B, Wattel F (2002) Small intestine intramucosal PCO(2) and microvascular blood flow during hypoxic and ischemic hypoxia. Crit Care Med 30:379–384
9.
Zurück zum Zitat Simic M, Vukovic R, Fabri M (1990) Damage in the hemato-enteral barrier in experimental liver transplantation. Acta Chir Iugosl 37:75–78 Simic M, Vukovic R, Fabri M (1990) Damage in the hemato-enteral barrier in experimental liver transplantation. Acta Chir Iugosl 37:75–78
10.
Zurück zum Zitat Liu P, Lu X, Han M (1998) Influence of portal triad clamping on the intestine in pigs. Hunan Yi Ke Da Xue Xue Bao 23:246–248PubMed Liu P, Lu X, Han M (1998) Influence of portal triad clamping on the intestine in pigs. Hunan Yi Ke Da Xue Xue Bao 23:246–248PubMed
11.
Zurück zum Zitat Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN (1970) Intestinal mucosal lesion in low flow states: a morphological, hemodynamic and metabolic reappraisal. Arch Surg 101:478–483PubMed Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN (1970) Intestinal mucosal lesion in low flow states: a morphological, hemodynamic and metabolic reappraisal. Arch Surg 101:478–483PubMed
12.
Zurück zum Zitat Fahrenkrug J (1979) Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function. Digestion 19:149–169PubMed Fahrenkrug J (1979) Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function. Digestion 19:149–169PubMed
13.
Zurück zum Zitat Holliger C, Radzyner M, Knoblauch M (1983) Effects of glucagon, vasoactive intestinal peptide, and vasopressin on villous microcirculation and superior mesenteric artery blood flow of the rat. Gastroenterology 85:1036–1043PubMed Holliger C, Radzyner M, Knoblauch M (1983) Effects of glucagon, vasoactive intestinal peptide, and vasopressin on villous microcirculation and superior mesenteric artery blood flow of the rat. Gastroenterology 85:1036–1043PubMed
14.
Zurück zum Zitat Janssen PJ, Gardiner SM, Compton AM, Bennett T (1991) Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats. Br J Pharmacol 102:123–134PubMed Janssen PJ, Gardiner SM, Compton AM, Bennett T (1991) Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats. Br J Pharmacol 102:123–134PubMed
15.
Zurück zum Zitat Ebenezar Mbianda Mbachu (2000) Effect of intravenous administration of VIP, GRP and a combination of l-ascorbic acid, dl-α tocopherol and DMSO on liver dysfunction and microcirculatory disturbances following injuries sustained during the reestablishment of blood flow to the rat small intestine. Dissertation, Cuvillier Verlag, Göttingen University, p 24. ISBN 3-89712-850-0 Ebenezar Mbianda Mbachu (2000) Effect of intravenous administration of VIP, GRP and a combination of l-ascorbic acid, dl-α tocopherol and DMSO on liver dysfunction and microcirculatory disturbances following injuries sustained during the reestablishment of blood flow to the rat small intestine. Dissertation, Cuvillier Verlag, Göttingen University, p 24. ISBN 3-89712-850-0
16.
Zurück zum Zitat Heuser M, Pfaar O, Gralla O, Gröne HJ, Nustede R, Post S (2000) Impact of gastrin-releasing peptide on intestinal microcirculation after ischemia-reperfusion in rats. Digestion 61:172–180CrossRefPubMed Heuser M, Pfaar O, Gralla O, Gröne HJ, Nustede R, Post S (2000) Impact of gastrin-releasing peptide on intestinal microcirculation after ischemia-reperfusion in rats. Digestion 61:172–180CrossRefPubMed
17.
Zurück zum Zitat Baatz H, Steinbauer M, Harris AG, Krombach F (1995) Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Int J Microcirc Clin Exp 15:85–91PubMed Baatz H, Steinbauer M, Harris AG, Krombach F (1995) Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Int J Microcirc Clin Exp 15:85–91PubMed
18.
Zurück zum Zitat Boyd AJ, Sherman IA, Saibil FG (1994) Intestinal microcirculation and leukocyte behavior in ischemia-reperfusion injury. Microvasc Res 47:355–368CrossRefPubMed Boyd AJ, Sherman IA, Saibil FG (1994) Intestinal microcirculation and leukocyte behavior in ischemia-reperfusion injury. Microvasc Res 47:355–368CrossRefPubMed
19.
Zurück zum Zitat Granger DN, Valleau JD, Parker RE, Lane RS, Taylor AE (1978) Effects of adenosine on intestinal hemodynamics, oxygen delivery, and capillary fluid exchange. Am J Physiol 235:707–719 Granger DN, Valleau JD, Parker RE, Lane RS, Taylor AE (1978) Effects of adenosine on intestinal hemodynamics, oxygen delivery, and capillary fluid exchange. Am J Physiol 235:707–719
20.
Zurück zum Zitat Xu D, Qi L, Guillory D, Cruz N, Berg R, Deitch EA (1993) Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J Trauma 34:676–682PubMed Xu D, Qi L, Guillory D, Cruz N, Berg R, Deitch EA (1993) Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J Trauma 34:676–682PubMed
21.
Zurück zum Zitat Lundgren O, Haglund U (1978) The pathophysiology of the intestinal counter-current exchanger. Life Sci 23:1411–1422CrossRefPubMed Lundgren O, Haglund U (1978) The pathophysiology of the intestinal counter-current exchanger. Life Sci 23:1411–1422CrossRefPubMed
22.
Zurück zum Zitat Haglund U, Lundgren O (1979) Non-occlusive acute intestinal vascular failure. Br J Surg 66:155–158PubMed Haglund U, Lundgren O (1979) Non-occlusive acute intestinal vascular failure. Br J Surg 66:155–158PubMed
23.
Zurück zum Zitat Gyongyosi M, Kaszaki J, Nemeth J, Wolfard A, Mojzes L, Farkas A (1997) Myocardial and gastrointestinal release of vasoactive intestinal peptide during experimental acute myocardial infarction. Coron Artery Dis 8:335–341PubMed Gyongyosi M, Kaszaki J, Nemeth J, Wolfard A, Mojzes L, Farkas A (1997) Myocardial and gastrointestinal release of vasoactive intestinal peptide during experimental acute myocardial infarction. Coron Artery Dis 8:335–341PubMed
24.
Zurück zum Zitat Finke U, Seifert J (1986) Differential effects of gastrointestinal hormones on the blood flow of the alimentary tract of the dog. Res Exp Med (Berl) 186:151–165 Finke U, Seifert J (1986) Differential effects of gastrointestinal hormones on the blood flow of the alimentary tract of the dog. Res Exp Med (Berl) 186:151–165
25.
Zurück zum Zitat Erspamer V, Melchiorri P, Sopranzi N (1972) The action of bombesin on the systemic arterial blood pressure of some experimental animals. Br J Pharmacol 45:442–450PubMed Erspamer V, Melchiorri P, Sopranzi N (1972) The action of bombesin on the systemic arterial blood pressure of some experimental animals. Br J Pharmacol 45:442–450PubMed
26.
Zurück zum Zitat Yang R, Liu Q, Unthank JL, Pescovitz MD, Grosfeld JL (1995) Preservation of postprandial intestinal hyperemic response after small bowel transplantation. J Pediatr Surg 30:1090–1092CrossRefPubMed Yang R, Liu Q, Unthank JL, Pescovitz MD, Grosfeld JL (1995) Preservation of postprandial intestinal hyperemic response after small bowel transplantation. J Pediatr Surg 30:1090–1092CrossRefPubMed
27.
Zurück zum Zitat Samel S, Keese M, Lanig S, Kleczka M, Gretz N, Hafner M, Sturm J, Post S (2003) Supplementation and inhibition of nitric oxide synthesis influences bacterial transit time during bacterial translocation in rats. Shock 19:378–382CrossRefPubMed Samel S, Keese M, Lanig S, Kleczka M, Gretz N, Hafner M, Sturm J, Post S (2003) Supplementation and inhibition of nitric oxide synthesis influences bacterial transit time during bacterial translocation in rats. Shock 19:378–382CrossRefPubMed
28.
Zurück zum Zitat Samel S, Lanig S, Lux A, Keese M, Gretz N, Nichterlein T, Sturm J, Lohr M, Post S (2002) The gut origin of bacterial pancreatic infection during acute experimental pancreatitis in rats. Pancreatology 2:449–455CrossRefPubMed Samel S, Lanig S, Lux A, Keese M, Gretz N, Nichterlein T, Sturm J, Lohr M, Post S (2002) The gut origin of bacterial pancreatic infection during acute experimental pancreatitis in rats. Pancreatology 2:449–455CrossRefPubMed
29.
Zurück zum Zitat Hotz HG, Foitzik T, Rohweder J, Schulzke JD, Fromm M, Runkel NS, Buhr HJ (1998) Intestinal microcirculation and gut permeability in acute pancreatitis: early changes and therapeutic implications. J Gastrointest Surg 2:518–525CrossRefPubMed Hotz HG, Foitzik T, Rohweder J, Schulzke JD, Fromm M, Runkel NS, Buhr HJ (1998) Intestinal microcirculation and gut permeability in acute pancreatitis: early changes and therapeutic implications. J Gastrointest Surg 2:518–525CrossRefPubMed
30.
Zurück zum Zitat Meyer K, Brown MF, Zibari G, Panes J, McMillan RW, McDonald JC, Granger DN (1998) ICAM-1 upregulation in distant tissues after hepatic ischemia/reperfusion: a clue to the mechanism of multiple organ failure. J Pediatr Surg 33:350–353CrossRefPubMed Meyer K, Brown MF, Zibari G, Panes J, McMillan RW, McDonald JC, Granger DN (1998) ICAM-1 upregulation in distant tissues after hepatic ischemia/reperfusion: a clue to the mechanism of multiple organ failure. J Pediatr Surg 33:350–353CrossRefPubMed
31.
Zurück zum Zitat Engler RL, Dahlgren MD, Peterson MA, Dobbs A, Schmid-Schönbein GW (1986) Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am J Physiol 251:93–100 Engler RL, Dahlgren MD, Peterson MA, Dobbs A, Schmid-Schönbein GW (1986) Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am J Physiol 251:93–100
32.
Zurück zum Zitat Beuk RJ, Heineman E, Tangelder GJ, Kurvers HA, Bonke HJ, oude Egbrink MG (1997) Effects of different durations of total warm ischemia of the gut on rat mesenteric microcirculation. J Surg Res 73:14–23CrossRefPubMed Beuk RJ, Heineman E, Tangelder GJ, Kurvers HA, Bonke HJ, oude Egbrink MG (1997) Effects of different durations of total warm ischemia of the gut on rat mesenteric microcirculation. J Surg Res 73:14–23CrossRefPubMed
33.
Zurück zum Zitat Weiss SJ (1986) Oxygen, ischemia and inflammation. Acta Physiol Scand Suppl 548:9–37PubMed Weiss SJ (1986) Oxygen, ischemia and inflammation. Acta Physiol Scand Suppl 548:9–37PubMed
34.
Zurück zum Zitat Brown MF, Ross AJ, Dasher J, Turley DL, Ziegler MM, O’Neill JA Jr (1990) The role of leukocytes in mediating mucosal injury of intestinal ischemia/reperfusion. J Pediatr Surg 25:214–216CrossRefPubMed Brown MF, Ross AJ, Dasher J, Turley DL, Ziegler MM, O’Neill JA Jr (1990) The role of leukocytes in mediating mucosal injury of intestinal ischemia/reperfusion. J Pediatr Surg 25:214–216CrossRefPubMed
35.
Zurück zum Zitat Tan S, McAdams M, Royall J, Freeman BA, Parks DA (1998) Endothelial injury from a circulating mediator following rat liver ischemia. Free Radic Biol Med 24:427–434CrossRefPubMed Tan S, McAdams M, Royall J, Freeman BA, Parks DA (1998) Endothelial injury from a circulating mediator following rat liver ischemia. Free Radic Biol Med 24:427–434CrossRefPubMed
36.
Zurück zum Zitat Kalfin R, Maulik N, Engelman RM, Cordis GA, Milenov K, Kasakov L, Das DK (1994) Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J Pharmacol Exp Ther 268:952–958PubMed Kalfin R, Maulik N, Engelman RM, Cordis GA, Milenov K, Kasakov L, Das DK (1994) Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J Pharmacol Exp Ther 268:952–958PubMed
37.
Zurück zum Zitat Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP (1999) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. J Immunol 162:2358–2367PubMed Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP (1999) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. J Immunol 162:2358–2367PubMed
38.
Zurück zum Zitat Delgado M, Gomariz RP, Martinez C, Abad C, Leceta J (2000) Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock. Eur J Immunol 30:3236–3246CrossRefPubMed Delgado M, Gomariz RP, Martinez C, Abad C, Leceta J (2000) Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock. Eur J Immunol 30:3236–3246CrossRefPubMed
Metadaten
Titel
Impact of vasoactive intestinal polypeptide and gastrin-releasing peptide on small bowel microcirculation and mucosal injury after hepatic ischemia/reperfusion in rats
verfasst von
Ingo Leister
J. Sydow
T. Stojanovic
L. Füzesi
B. Sattler
M. Heuser
H. Becker
P. M. Markus
Publikationsdatum
01.01.2005
Erschienen in
International Journal of Colorectal Disease / Ausgabe 1/2005
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-004-0610-8

Weitere Artikel der Ausgabe 1/2005

International Journal of Colorectal Disease 1/2005 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.